JT
Joseph Todisco
Chief Executive OfficerDirector

Joseph Todisco insider trades: CorMedix (CRMD) stock buys and sales

Chief Executive Officer, CorMedix Last trade Dec 18, 2025 36 Form 4 filings
$360K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2019
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Joseph reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 18, 2025CRMD↓ Sell$360K
Sep 12, 2025CRMD↓ Sell$650K
Mar 13, 2024CRMD↑ Buy$51K
Sep 8, 2023CRMD↑ Buy$37K
Nov 15, 2022CRMD↑ Buy$76K
Aug 24, 2022CRMD↑ Buy$18K
May 16, 2022CRMD↑ Buy$34K
Dec 2, 2021AMRX↓ Sell$6K
Mar 15, 2021AMRX↓ Sell$248K
Feb 28, 2020AMRX↑ Buy$145K
May 13, 2019AMRX↑ Buy$148K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CRMD insiders

Open-market trades in the last 12 months

About Joseph Todisco's insider trades

Joseph Todisco is Chief Executive Officer at CorMedix (CRMD). Since May 13, 2019, Joseph has reported 7 open-market purchases worth $509K and 4 sales worth $1.3M on SEC Form 4. In the last 12 months: 1 sale ($360K).

Their filings also include shares withheld for taxes (16 filings), grants and awards (13 filings), option exercises (13 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.